{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T14:20:36Z","timestamp":1700576436771},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.mehy.2014.05.005","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T21:00:32Z","timestamp":1400619632000},"page":"154-159","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Are GATA1 mutations occurring at random in Down syndrome transient leukemia?"],"prefix":"10.1016","volume":"83","author":[{"given":"Daniel","family":"Satg\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2014.05.005_b0005","series-title":"The biology of cancer","article-title":"Maintenance of genomic integrity and development of cancer","author":"Weinberg","year":"2007"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.005_b0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/bies.201100022","article-title":"In defense of the somatic mutation theory of cancer","volume":"33","author":"Vaux","year":"2011","journal-title":"Bioessays"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.005_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hoc.2009.11.009","article-title":"Acute leukemias in children with Down syndrome","volume":"24","author":"Zwaan","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.005_b0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2013-03-491936","article-title":"Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome","volume":"122","author":"Nikolaev","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.005_b0025","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1182\/blood-2003-10-3383","article-title":"Natural history of GATA1 mutations in Down syndrome","volume":"103","author":"Ahmed","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.mehy.2014.05.005_b0030","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1182\/blood-2007-01-069542","article-title":"Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome","volume":"110","author":"Pine","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.005_b0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bjh.12041","article-title":"Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder","volume":"159","author":"Gamis","year":"2012","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1016\/j.mehy.2014.05.005_b0040","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1073\/pnas.85.16.5976","article-title":"An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes","volume":"85","author":"Evans","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2014.05.005_b0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1756-8722-5-45","article-title":"The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cells","volume":"5","author":"Halsey","year":"2012","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.005_b0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng955","article-title":"Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome","volume":"32","author":"Wechsler","year":"2002","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.mehy.2014.05.005_b0055","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1182\/blood-2011-03-342774","article-title":"Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia","volume":"118","author":"Alford","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.005_b0060","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood-2005-02-0551","article-title":"Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development","volume":"106","author":"Muntean","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.mehy.2014.05.005_b0065","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1182\/blood.V93.9.2867","article-title":"Consequences of GATA-1 deficiency in megakaryocytes and platelets","volume":"93","author":"Vyas","year":"1999","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.005_b0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bcmd.2013.07.008","article-title":"The impact of trisomy 21 on foetal haematopoiesis","volume":"51","author":"Roberts","year":"2013","journal-title":"Blood Cells Mol Dis"},{"issue":"13","key":"10.1016\/j.mehy.2014.05.005_b0075","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood-2008-11-190330","article-title":"Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome","volume":"114","author":"Cabelof","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.005_b0080","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1371\/journal.pgen.0020050","article-title":"Understanding the basis for Down syndrome phenotypes","volume":"2","author":"Roper","year":"2006","journal-title":"PLoS Genet"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.005_b0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mad.2011.10.001","article-title":"Down syndrome as a model of DNA polymerase beta haploinsufficiency and accelerated aging","volume":"133","author":"Patterson","year":"2012","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.mehy.2014.05.005_b0090","doi-asserted-by":"crossref","first-page":"724904","DOI":"10.1155\/2012\/724904","article-title":"Oxidative stress and down Syndrome: a route toward Alzheimer-like dementia","volume":"2012","author":"Perluigi","year":"2012","journal-title":"Curr Gerontol Geriatr Res"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.005_b0095","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.annepidem.2012.09.005","article-title":"Systemic oxidative stress, as measured by urinary allantoin and F(2)-isoprostanes, is not increased in Down syndrome","volume":"22","author":"Tolun","year":"2012","journal-title":"Ann Epidemiol"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.005_b0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0047-6374(97)00121-8","article-title":"Trisomy 21 and accelerated aging: DNA-repair parameters in peripheral lymphocytes of Down\u2019s syndrome patients","volume":"100","author":"Raji","year":"1998","journal-title":"Mech Ageing Dev"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2014.05.005_b0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0022-510X(85)90011-5","article-title":"Hypersensitivity to ionizing radiation in cultured cells from Down syndrome patients","volume":"69","author":"Otsuka","year":"1985","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.005_b0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0165-4608(93)90127-8","article-title":"X-ray-induced chromatid damage in cells from Down syndrome and Alzheimer disease patients in relation to DNA repair and cancer proneness","volume":"70","author":"Sanford","year":"1993","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.005_b0115","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2006.04.167","article-title":"Age-dependent oxidative stress-induced DNA damage in Down\u2019s lymphocytes","volume":"345","author":"Zana","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.mehy.2014.05.005_b0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.semcancer.2008.03.020","article-title":"Carcinogenesis in Down syndrome; What can be learned from trisomy 21?","volume":"18","author":"Satg\u00e9","year":"2008","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.005_b0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.0.CO;2-M","article-title":"A tumor profile in Down syndrome","volume":"78","author":"Satg\u00e9","year":"1998","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.005_b0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.11212","article-title":"Are solid tumours different in children with Down\u2019s syndrome?","volume":"106","author":"Satg\u00e9","year":"2003","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.005_b0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF03006929","article-title":"Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome","volume":"86","author":"Kanegane","year":"2007","journal-title":"Int J Hematol"},{"issue":"24","key":"10.1016\/j.mehy.2014.05.005_b0140","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2013-07-515148","article-title":"GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia","volume":"122","author":"Roberts","year":"2013","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2014.05.005_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2008.09.018","article-title":"Human phenotypes associated with GATA-1 mutations","volume":"427","author":"Ciovacco","year":"2008","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.mehy.2014.05.005_b0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/bjh.12184","article-title":"A novel GATA1 mutation (Stop414Arg) in a family with the rare X-linked blood group Lu(a-b-) phenotype and mild macrothrombocytic thrombocytopenia","volume":"161","author":"Singleton","year":"2013","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.005_b0155","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ng1825","article-title":"An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis","volume":"38","author":"Hollanda","year":"2006","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.mehy.2014.05.005_b0160","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1172\/JCI63597","article-title":"Exome sequencing identifies GATA1 mutations resulting in Diamond\u2013Blackfan anemia","volume":"122","author":"Sankaran","year":"2012","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2014.05.005_b0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0027-5107(98)00024-4","article-title":"Atypical background somatic mutant frequencies at the HPRT locus in children and adults with Down syndrome","volume":"403","author":"Finette","year":"1998","journal-title":"Mutat Res"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.005_b0170","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2008-05-157859","article-title":"Trisomy 21 enhances human fetal erythro-megakaryocytic development","volume":"112","author":"Chou","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.005_b0175","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1182\/blood-2008-04-152967","article-title":"Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations","volume":"112","author":"Tunstall-Pedoe","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mehy.2014.05.005_b0180","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2141.2008.07332.x","article-title":"Megakaryocyte hyperproliferation without GATA1 mutation in foetal liver of a case of Down syndrome with hydrops foetalis","volume":"143","author":"De Vita","year":"2008","journal-title":"Br J Haematol"},{"issue":"46","key":"10.1016\/j.mehy.2014.05.005_b0185","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1038\/onc.2010.351","article-title":"Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down\u2019s syndrome","volume":"29","author":"De Vita","year":"2010","journal-title":"Oncogene"},{"issue":"43","key":"10.1016\/j.mehy.2014.05.005_b0190","doi-asserted-by":"crossref","first-page":"17579","DOI":"10.1073\/pnas.1211405109","article-title":"Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21","volume":"109","author":"Roy","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7132","key":"10.1016\/j.mehy.2014.05.005_b0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.mehy.2014.05.005_b0200","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/01.mph.0000212997.02554.f6","article-title":"Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder","volume":"28","author":"Xu","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.005_b0205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrg3152","article-title":"Transcription as a source of genome instability","volume":"13","author":"Kim","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.005_b0210","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/embor.2012.165","article-title":"Genomic evidence for elevated mutation rates in highly expressed genes","volume":"13","author":"Park","year":"2012","journal-title":"EMBO Rep"},{"issue":"17","key":"10.1016\/j.mehy.2014.05.005_b0215","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1073\/pnas.1003586107","article-title":"Fetal liver hepatic progenitors are supportive stromal cells for hematopoietic stem cells","volume":"107","author":"Chou","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"10.1016\/j.mehy.2014.05.005_b0220","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1101\/gad.1903410","article-title":"Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis","volume":"24","author":"Klusmann","year":"2010","journal-title":"Genes Dev"},{"issue":"8","key":"10.1016\/j.mehy.2014.05.005_b0225","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.dnarep.2008.04.015","article-title":"Gene transcription increases DNA damage-induced mutagenesis in mammalian stem cells","volume":"7","author":"Hendriks","year":"2008","journal-title":"DNA Repair (Amst)"},{"issue":"3","key":"10.1016\/j.mehy.2014.05.005_b0230","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrc3006","article-title":"Transcriptional mutagenesis: causes and involvement in tumour development","volume":"11","author":"Br\u00e9geon","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.mehy.2014.05.005_b0235","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/jcp.24400","article-title":"Transcriptional mutagenesis and its potential roles in the etiology of cancer and bacterial antibiotic resistance","volume":"228","author":"Morreall","year":"2013","journal-title":"J Cell Physiol"},{"issue":"7278","key":"10.1016\/j.mehy.2014.05.005_b0240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature08658","article-title":"A comprehensive catalogue of somatic mutations from a human cancer genome","volume":"463","author":"Pleasance","year":"2010","journal-title":"Nature"},{"issue":"51","key":"10.1016\/j.mehy.2014.05.005_b0245","doi-asserted-by":"crossref","first-page":"21766","DOI":"10.1073\/pnas.0912499106","article-title":"Mutation patterns in cancer genomes","volume":"106","author":"Rubin","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.mehy.2014.05.005_b0250","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1128\/MCB.25.4.1215-1227.2005","article-title":"GATA1 function, a paradigm for transcription factors in hematopoiesis","volume":"25","author":"Ferreira","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"6175","key":"10.1016\/j.mehy.2014.05.005_b0255","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1247472","article-title":"Medicine. Combating evolution to fight disease","volume":"343","author":"Rosenberg","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.mehy.2014.05.005_b0260","doi-asserted-by":"crossref","DOI":"10.1002\/9780470015902.a0024465","article-title":"Analysis of somatic mutations in cancer tissues challenges the somatic mutation theory of cancer","author":"Satg\u00e9","year":"2013"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714002096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714002096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T17:46:16Z","timestamp":1597859176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987714002096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0306987714002096"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2014.05.005","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are GATA1 mutations occurring at random in Down syndrome transient leukemia?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2014.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}